BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29662631)

  • 21. Genetic abnormalities assist in pathological diagnosis and EBV-positive cell density impact survival in Chinese angioimmunoblastic T-cell lymphoma patients.
    Shi Y; Wang H; Liu Y; Long M; Ding N; Mi L; Lai Y; Zhou L; Diao X; Li X; Liu W; Zhu J
    Chin J Cancer Res; 2023 Oct; 35(5):536-549. PubMed ID: 37969960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expressions of CXCL13, CD10 and bcl-6 in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified].
    Tang XF; Li GD; Li YL; Liang DN; Xia T; Zhou JY; Yao YQ; Wu WQ; Wang ZG; Yang YH; Tang XB; Bai YQ; Ding Q
    Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):224-30. PubMed ID: 19575892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological features of programmed cell death-1 and programmed cell death-ligand-1 expression in the tumor cells and tumor microenvironment of angioimmunoblastic T cell lymphoma and peripheral T cell lymphoma not otherwise specified.
    Kim S; Kwon D; Koh J; Nam SJ; Kim YA; Kim TM; Kim CW; Jeon YK
    Virchows Arch; 2020 Jul; 477(1):131-142. PubMed ID: 32170448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathologic and molecular insights in nodal T-follicular helper cell lymphomas.
    Marques-Piubelli ML; Amador C; Vega F
    Front Oncol; 2023; 13():1105651. PubMed ID: 36793612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Epigenetic Modifier Mutations in Peripheral T-Cell Lymphomas.
    Tigu AB; Bancos A
    Curr Issues Mol Biol; 2023 Nov; 45(11):8974-8988. PubMed ID: 37998740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation analysis links angioimmunoblastic T-cell lymphoma to clonal hematopoiesis and smoking.
    Cheng S; Zhang W; Inghirami G; Tam W
    Elife; 2021 Sep; 10():. PubMed ID: 34581268
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and related lymphomas using quantitative allele-specific PCR.
    Nakamoto-Matsubara R; Sakata-Yanagimoto M; Enami T; Yoshida K; Yanagimoto S; Shiozawa Y; Nanmoku T; Satomi K; Muto H; Obara N; Kato T; Kurita N; Yokoyama Y; Izutsu K; Ota Y; Sanada M; Shimizu S; Komeno T; Sato Y; Ito T; Kitabayashi I; Takeuchi K; Nakamura N; Ogawa S; Chiba S
    PLoS One; 2014; 9(10):e109714. PubMed ID: 25310466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma.
    Lee YP; Yoon SE; Cho J; Ko YH; Jo H; Kim SJ; Kim WS
    Ann Hematol; 2022 Jul; 101(7):1535-1543. PubMed ID: 35639152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma.
    Maura F; Agnelli L; Leongamornlert D; Bolli N; Chan WC; Dodero A; Carniti C; Heavican TB; Pellegrinelli A; Pruneri G; Butler A; Bhosle SG; Chiappella A; Di Rocco A; Zinzani PL; Zaja F; Piva R; Inghirami G; Wang W; Palomero T; Iqbal J; Neri A; Campbell PJ; Corradini P
    Am J Hematol; 2019 Jun; 94(6):628-634. PubMed ID: 30829413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follicular helper T-cells: expanding roles in T-cell lymphoma and targets for treatment.
    Ahearne MJ; Allchin RL; Fox CP; Wagner SD
    Br J Haematol; 2014 Aug; 166(3):326-35. PubMed ID: 24815671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mutation characteristics of angioimmunoblastic T-cell lymphoma: an analysis of 75 cases].
    Shen X; Yi HM; Li AQ; Ouyang BS; Dong L; Wang CF
    Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):29-33. PubMed ID: 38178743
    [No Abstract]   [Full Text] [Related]  

  • 32. Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas.
    Ye Y; Ding N; Mi L; Shi Y; Liu W; Song Y; Shu S; Zhu J
    Exp Hematol Oncol; 2021 Feb; 10(1):9. PubMed ID: 33546774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angioimmunoblastic T-cell lymphoma and Kaposi sarcoma: A fortuitous collision?
    Poullot E; Milowich D; Lemonnier F; Bisig B; Robe C; Pelletier L; Letourneau A; Dupuy A; Sako N; Ketterer N; Carde P; Dartigues P; Delfau-Larue MH; de Leval L; Gaulard P
    Histopathology; 2024 Feb; 84(3):556-564. PubMed ID: 37988271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells.
    Dupuis J; Boye K; Martin N; Copie-Bergman C; Plonquet A; Fabiani B; Baglin AC; Haioun C; Delfau-Larue MH; Gaulard P
    Am J Surg Pathol; 2006 Apr; 30(4):490-4. PubMed ID: 16625095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RHOA G17V mutation in angioimmunoblastic T-cell lymphoma: A potential biomarker for cytological assessment.
    Lee PH; Weng SW; Liu TT; You HL; Liao CK; Wang MC; Huang WT
    Exp Mol Pathol; 2019 Oct; 110():104294. PubMed ID: 31394087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients.
    de Pádua Covas Lage LA; Barreto GC; Culler HF; Cavalcante JB; de Oliveira Alves LB; Nardinelli L; Bendit I; Zerbini MCN; Rocha V; Pereira J
    Cancer Biomark; 2022; 35(2):179-191. PubMed ID: 36093687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Peripheral T-cell lymphoma with follicular helper of T cell phenotype of Waldeyer's ring: a clinicopathological and genetic study of eight cases].
    Zhang DD; Li P; Hu PZ; Wang GN; Zhao WG; Zhang YP; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2020 Jul; 49(7):686-692. PubMed ID: 32610379
    [No Abstract]   [Full Text] [Related]  

  • 38. IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment.
    Leca J; Lemonnier F; Meydan C; Foox J; El Ghamrasni S; Mboumba DL; Duncan GS; Fortin J; Sakamoto T; Tobin C; Hodgson K; Haight J; Smith LK; Elia AJ; Butler D; Berger T; de Leval L; Mason CE; Melnick A; Gaulard P; Mak TW
    Cancer Cell; 2023 Feb; 41(2):323-339.e10. PubMed ID: 36736318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma.
    Wang C; McKeithan TW; Gong Q; Zhang W; Bouska A; Rosenwald A; Gascoyne RD; Wu X; Wang J; Muhammad Z; Jiang B; Rohr J; Cannon A; Steidl C; Fu K; Li Y; Hung S; Weisenburger DD; Greiner TC; Smith L; Ott G; Rogan EG; Staudt LM; Vose J; Iqbal J; Chan WC
    Blood; 2015 Oct; 126(15):1741-52. PubMed ID: 26268241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis.
    Butzmann A; Sridhar K; Jangam D; Kumar J; Sahoo MK; Shahmarvand N; Warnke R; Rangasamy E; Pinsky BA; Ohgami RS
    Int J Mol Med; 2020 Oct; 46(4):1466-1476. PubMed ID: 32945366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.